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Rima Ahmed .N. Hashm Tumia 
 
ROLE OF eIF3a EXPRESSION IN CELLULAR SENSITIVITY TO IONIZING 
RADIATION TREATMENTS BY REGULATING SYNTHESIS OF NHEJ REPAIR 
PROTEINS 
 
Translation Initiation in protein synthesis is a crucial step controlling gene 
expression that enhanced by eukaryotic translation initiation factors (eIFs).  eIF3a, the 
largest subunit of eIF3 complexes, has been shown to regulate protein synthesis and 
cellular response to cisplatin treatment. Its expression has also been shown to negatively 
associate with prognosis. In this study, we tested a hypothesis that eIF3a regulates synthesis 
of proteins important for repair of double strand DNA breaks induced by ionizing radiation 
(IR). We found that eIF3a up-regulation sensitizes cellular response to IR while its 
knockdown causes resistance to IR. We also found that eIF3a over-expression increases 
IR-induced DNA damage and decreases Non-Homologous End Joining (NHEJ) activity by 
suppressing expression level of NHEJ repair proteins such as DNA-PKcs and vice versa. 
Together, we conclude that eIF3a plays an important role in cellular response to DNA-
damaging treatments by regulating synthesis of DNA repair proteins and, thus, eIIF3a 
likely plays an important role in the outcome of cancer patients treated with DNA-
damaging strategies including ionizing radiation.   
Ahmed Safa, PhD, Chair 
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Introduction 
 
Eukaryotic initiation factors (eIFs) are a family of proteins that play important roles 
in mRNA translation and protein synthesis. Recent growing evidence suggest that eIFs do 
not just participate in translation initiation of global mRNAs but may also regulate 
synthesis of a subset of proteins [1, 2]. These regulatory functions have been thought to 
contribute to the potential oncogenic role of eIFs. Indeed, many eIFs were found to have 
increased expression in human tumors and have been shown to have oncogenic activity. 
One of these eIFs, eIF3a, has been found to overexpress in many human cancers including 
cancers of breast [3], cervix [4], esophagus [5], stomach [6], lung [7], bladder [8] and it 
was thought to be a proto-oncogene. Indeed, knocking down eIF3a reversed the malignant 
phenotype of human cancer cells [9] while over-expressing ectopic eIF3a transformed 
NIH3T3 fibroblast cells [10] in vitro. Most recently, it was found that over-expressing 
ectopic eIF3a transformed normal intestinal epithelial cells, which developed into tumors 
in vivo [11]. 
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FIGURE 1 
 
 
Figure 1. Overview of translation initiation in eukaryotic. eIF3 has multiple functions 
in translation initiation starting from the dissociation of the 60s and 40s subunits from each 
other. eIF3a promotes the separation of the two subunits by binding of the eIF3a to the 4os 
subunit and participating in the recruitment of eIF1A and the ternary complex to 40s 
subunits to form the 43s preinitiation complex (PIC). It is also required for the mRNA 
recruitment to PIC for scanning of the start codon AUG. 60s subunit will bind again to the 
40s subunit to form the 80s initiation complex. 
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Interestingly, it has also been observed that eIF3a expression associates with 
clinical outcome and prognsosis of esophageal, cervical, lung, bladder, ovarian, and oral 
cancer patients [4, 5, 8, 12-14]. While patients with lower eIF3a level had poor prognosis, 
patients with higher eIF3a level had better prognosis, Indeed, eIF3a knockdown resulted 
in cellular resistance to cisplatin, a common constituent in chemotherapeutic regimens for 
treating these cancers possibly by regulating nucleotide excision repair (NER) via 
increasing the synthesis of NER proteins [15]. It has also been shown that eIF3a up-
regulation increases cellular sensitivity to anticancer drug doxorubicin, which causes DNA 
double strand breaks (DSBs) by inhibiting topoisomerase II [14].  
Extensive DSBs induced by various exogenous and endogenous factors are one of 
the most fatal forms of DNA damages [16, 17] and are taken advantage of for treating 
human cancers in the form of chemo and radiation therapy. However, cells with efficient 
repair of DSBs are able to survive these treatments that cause DSBs using two two major 
mechanisms of repair of DSBs, homologous recombination (HR) and nonhomologous end-
joining (NHEJ) [18, 19]. While HR repairs the damages using undamaged and symmetrical 
chromosome as a template during S or G phase of cell cycle [16], [20], NHEJ repairs DSBs 
throughout all cell cycle phases and is the pathway in repairing ionizing radiation (IR)-
induced DSBs [21-23]. The major proteins important in NHEJ repair of DSBs include Ku 
(Ku70, Ku80) and DNA-PKcs  to form the DNA-PK holoenzyme [24-27]. Because IR is a 
common and an important strategy for treating many types of human cancers [28-30], it is 
of interest to invesitgate if eIF3a possibly contributes repair of DSBs by regulating 
synthesis of proteins important for these repairs and, ultimately, cellular response to IR 
treatments that cause DSBs. Here, we found that eIF3a plays an important role in cellular 
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response to IR treatments by regulating NHEJ repair via inhibiting synthesis of NHEJ 
repair proteins including Ku70, K80, and DNA-PKcs. All of the observation apparently 
showed that changing the level of eIF3a has an additional non canonical function in 
suppressing translation of  some crucial repair proteins. 
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FIGURE 2 
 
 
Figure 2. Patterns of eIF3a in regulating the cellular response to ionizing radiation 
treatments. eIF3a regulates NHEJ repair activity that repairs the DNA double strand break 
induced by ionizing radiation. Changing the level of eIF3a enhance or suppress the cellular 
sensitivity to IR treatments by regulating the DNA repair pathways. 
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Materials and Methods 
 
A. Materials.  
Cell culture mediums and reagents (DMEM, fetal bovine serum, and trypsin-
versene mixture) were purchased from BioSources International (Camarillo, CA), Media 
Tech (Herndon, CA), or Cambrex (Walkersvill, MD). All electrophoresis reagents, 
polyvinylidene difluoride (PVDF) membranes were purchased from Bio-Rad (Hercules, 
CA). SYBR Green PCR master Mix for real-time PCR was purchased from Applied 
Biosystems by life technologies (Warrington, UK) and the high capacity cDNA reverse 
transcription kit from Applied Biosystems (Foster City, CA).  All primers was used from 
Invitrogen. Metafectene® pro was purchased from Biontex (San Diego, CA). All other 
chemicals and reagents were of molecular biology grade from Sigma (St. Louis, MO) or 
Fisher Scientific (Chicago, IL). 
 
B. Cell culture. 
Human lung cancer cell line H1299 and rat intestinal epithelium cell line RIE 
were cultured at 37°C with 5% CO2 in RPMI 1640 and DMEM medium respectively, 
supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100 μg/ml 
streptomycin and 400 µg/ml G418.  
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C. Survival assay. 
Colony formation survival assay was performed following IR treatments as 
previously described [31]. Briefly, 100 cells/well were seeded in 6-well plates and using 
of 2ml DMEM for RIE cells and PRMI for H1299 cultured for 24 hrs followed by 
treatments with different doses of IR and continuous culture for 10-14 days with media 
changed every 2-3 days. At the end of the study, cells were washed with PBS and the 
colonies were stained with 0.05% (w/v) crystal violet in phosphate-buffered saline (PBS) 
containing 20% methanol for 15 minutes at room temperature and counted manually. 
 
D. Western blot analysis. 
Western blot analysis to measure the amount of protein expression western blot 
analysis was performed using 2% SDS –PAGE as previously described [32, 33]. Briefly, 
24 hours after seeding the cells the old media was removed and the cells were washed with 
cold PBS and collected in small Eppendorf tubes after scraping them by scraper to remove 
all of the cells from the plate.  To perform the protein concentration measurement the cells 
were span down for 15 seconds at 12600 RPM and lysed with lysis buffer TNN- sodium 
dodecyl sulfate (SDS) buffer (50 mM Tris-HCl (ph 7.5), 150 mM NaCl, 0.5 % NP-40, 5 
mM EDTA, 50 mM NaF, 1 mM Na3VO3, with 1 mM DTT and 10 mM PMSF) incubated 
for 30 minutes on ice followed by sonication and centrifugation at 4 °C to collect the cells 
supernatant and discard the pellets. The protein concentration of cell lysates was 
determined using BioRad protein assay kit. For Western blot analysis, equal amount of 
proteins from different cells were separated by SDS-PAGE, transferred to PVDF 
membranes, and probed with antibodies specific to eIF3a, γ-H2AX, Ku70, Ku80, DNA-
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PKcs, and actin control followed by probing with HRP-conjugated secondary antibody and 
ECL. The signals are captured on x-ray films. 
 
E. Immunofluorescence Imaging. 
 Immunofluorescence staining was performed by culturing RIE and H1299 cells on 
glass coverslips, which were washed twice with cold PBS and fixed with an 
acetone/methanol mixture (1:1) for 10 min and blocked at 4 °C for 30 min with a blocking 
solution (1% BSA and 1% normal horse serum in PBS). The coverslips were then probed 
with the primary antibody γ-H2AX-specific antibody for 30 min at 4°C followed by 
incubation with FITC-conjugated secondary antibody goat anti-mouse IgG at room 
temperature for 30 minutes and washed twice with PBS. The cells were counter stained 
with DAPI before viewing on a confocal microscope. 
 
F. Real-time RT-PCR. 
Real-time reverse transcription (RT)-PCR was performed as described previously 
[32].  Briefly, total RNA was extracted using RNeasy Mini Kit (Qiagen, Valencia, CA) 
and real-time RT-PCR were performed using Power SYBR Green RNA-to-CT 1-Step kit 
(Applied Biosystems) Data were normalized to an internal control gene, glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). Primer pairs used were; 5-
CATGGCAACTCCAGAGCAG (forward) and GCTCCTTAAACTCATCCACC 
(reverse) for Ku70. AGAAGAAGGCCAGCTTTGAG (forward) and 
AGCTGTGACAGAACTTCCAG (reverse) for Ku80. 
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CCGGACGGACCTACTACGACT (forward) and AGAACGACCTGGGCATCCT 
(reverse) for DNA-PKcs. 
 
G. Comet assay. 
 Comet assay was performed by embedding cells in low melting agarose (Trevigen) 
on a microscope slide which allowed to set for 1 hour at 4°C followed by incubation the 
slides in a pre-chilled lysis neutral pH solution (Trevigen, 4250-050-01) at 4°C for 30 min 
in the dark, then electrophoresis in TBE buffer for 2 hours using a Comet assay kit 
(Trevigen, Gaithersburg, MD) instructed by the manufacturer. To measure the DNA 
Double-strand break (DSB) damage following IR treatments, comets tails were observed 
by Zeiss Axiovert 25 fluorescent microscope equipped with a camera, and analyzed with 
CometScore V1.5 (TriTek, Sumerduck, VA) after staining the cells with SYBR Green I 
and scoring 120 cells in each sample to measure the olive tail moment. 
 
H. Host cell reactivation-based NHEJ assay.  
For host cell reactivation NHEJ assay, pGL3 reporter plasmid with firefly luciferase 
gene driven by CMV promoter was used, first by linearization of the plasmid using HindIII 
digestion. The TK-Renilla luciferase plasmid was used as a control and co-transfected with 
the linearized pGL3 plasmid followed by determination of both firefly and Renilla 
luciferase activity. Expression of firefly luciferase is dependent on repair of the plasmid to 
re-generate the circular plasmid via NHEJ. 
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I. Protein stability assay. 
 Cells were treated with 10µ/ml Cycloheximide in a time course experiment and 
harvested at several time points followed by collection of cells for western blotting 
analysis. Whole-cell lysates were prepared as described previously [34]. Scanned images 
were quantified using ImageJ (NIH, USA) software. 
 
J. Pulse labeling and Immunoprecipitation.  
Pulse labeling and pulse chase experiments were performed as previously described 
[9, 32]. Briefly, cells were washed with PBS twice, methionine-free media, and the pulse 
labeled with [35S] methionine (10 µCi/µl) in methionine-free media for 2 hours. The cells 
were then washed with PBS three times, collected for cell lysate preparation and 
immunoprecipitation.  
Immunoprecipitation was performed as previously described [32]. Briefly, the cell 
lysates were first mixed with mouse IgG and incubated for 2 hrs at 4°C followed by 
addition of 50% protein G-agarose slurry and incubation for 3 hrs at 4°C to remove 
nonspecifically-bound proteins by centrifugation. The supernatant was transferred to a new 
tube and incubated with 5µg of primary antibodies against Ku70, Ku80 and DNA-PKcs at 
4°C for 2 hr. Finally, 50µl of 50% protein G-agarose beads was added to the mixtures, 
incubated at 4°C overnight and then washed with lysis buffer 5 times and separated with 
SDS-PAGE. 
 
 
 
  
11 
Results 
 
A. Role of eIF3a in cellular response to IR treatment. 
To determine the potential role of eIF3a in cellular response to IR, we first knocked 
down eIF3a expression using siRNA in H1299 cells, which have high level of endogenous 
eIF3a (Fig. 3A) followed by analysis of cellular response to IR using colony formation 
assay. As shown in Fig. 3A and 3C, H1299 cells with eIF3a knockdown (H1299/Si) are 
significantly more resistant with a 2-fold increase in relative resistance factor (RRF) than 
the control H1299 cells transfected with scrambled siRNA (H1299/Scr). To confirm this 
observation, we performed a reverse experiment by taking advantage of the previously 
established stable RIE cells with eIF3a over-expression (RIE/eIF3a) (see Fig. 1C) [11] and 
tested its response to IR in comparison with control cells transfected with empty vector 
(RIE/Vec). As shown in Fig. 3B and 3C, RIE/eIF3a cells with eIF3a over-expression are 
remarkably more sensitive than the control RIE/Vec cells to IR with a 2-fold reduction in 
RRF. Thus, eIF3a expression may affect cellular response to IR treatments. 
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FIGURE 3 
 
 
Figure 3. Effect of eIF3a expression on cellular response to IR. H1299 with transient 
eIF3a knockdown (A) and RIE cells with stable eIF3a over-expression (B) as well as their 
respective controls were subjected to Western blot analysis of eIF3a expression and colony 
formation assay following treatment with IR. Panel C shows summary of eIF3a effect on 
cellular sensitivity to IR treatments. Relative resistance factor (RRF) was derived by 
dividing the IC50 of the test cells by that of their control cells. (n=3, *p<0.05, **p<0.01). 
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B. Effect of eIF3a on γH2AX recruitment induced by IR. 
To investigate how eIF3a affect cellular response to IR, we tested the hypothesis 
that eIF3a may regulate repair of DSB induced by IR. For this purpose, we first tested the 
effect of eIF3a on γ-H2AX expression, a marker for DSB [35], following IR treatment. As 
shown in Fig. 4A, γ-H2AX level was detected in either H1299/Si or the control H1299/Scr 
cells. However, γ-H2AX expression drastically increased following IR treatment in these 
cells at 20 min after IR treatment. Interestingly, at 6 hours after IR, γ-H2AX in H1299/Si 
cells returned essentially to the basal level while remained at high level in the control 
H1299/Scr cells. This finding suggests that eIF3a expression may suppress repair of DSB 
induced by IR. We also performed similar experiments using RIE/eIF3a and RIE/Vec cells 
and found that eIF3a over-expression clearly delays DNA repair as indicated by the delayed 
disappearance of γ-H2AX (Fig. 4A), consistent with the findings using H1299/Si and 
H1299/Scr cells.   
To verify above findings, immunofluorescence staining of γ-H2AX in the nuclei of 
these cells was detected at 2 and 6 hours after IR exposure.  As shown in Fig. 4B, the 
punctate staining of γ-H2AX in the nuclei of H1299/Si cells disappeared at 6 hrs following 
IR while maintaining a high level in the control H1299/Scr cells. RIE/eIF3a cells retains 
high level of γ-H2AX whereas the control RIE/Vec cells lost γ-H2AX staining at 6 hrs 
following IR. These observations are consistent with the results shown using Western blot 
analysis. Thus, it is possible that eIF3a expression may inhibit repair of DSB induced by 
IR. 
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FIGURE 4 
 
 
Figure 4. Effect of eIF3a on IR-induced γ-H2AX. Western blot (A) and 
immunofluorescence staining (B) analyses of γ-H2AX in H1299 cells with transient eIF3a 
knockdown and RIE cells with stable eIF3a over-expression as well as their respective 
controls following IR treatments.   
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C. Effect of eIF3a on DNA damage induced by ionizing radiation (IR). 
In above studies, we used a γ-H2AX, a DNA damage marker, to evaluate DNA 
damage and repair. To directly evaluate DNA damages induced by IR in the presence of 
different levels of eIF3a, we performed neutral comet assay.  As shown in Fig. 5A, 
H1299/Si cells clearly have significantly lower Olive tail moment than the control 
H1299/Scr cells at both 2 hrs and 6 hrs following IR treatment. Consistently, RIE/eIF3a 
cells have significantly higher Oliver tail moment than the control RIE/Vec cells (Fig. 5B) 
following IR treatment.  Thus, eIF3a expression likely inhibit repair of DSB induced by IR 
and cells with high levels of eIF3a will retain higher levels of DSBs following IR while 
cells with lower eIF3a retains lower level of DSBs possibly due to activated repair of DSBs 
in the absence of eIF3a. 
 
 
 
 
 
 
 
 
 
 
 
 
  
16 
FIGURE 5 
 
 
Figure 5. Comet Assay. The effect of eIF3a on the level of DSBs induced by IR were 
tested in H1299 cells with transient eIF3a knockdown (A) and RIE cells with stable eIF3a 
over-expression (B) as well as their respective control cells. The histograms show the 
summary of quantitative analysis of Olive tail moment in these cells. (n=3; *p<0.05, 
**<0.01). 
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D. Role of eIF3a in NHEJ repair of DSB.  
 To determine if eIF3a regulates repairs of DSBs, we next performed host cell 
reactivation (HCR) assay of NHEJ activity since NHEJ is the main repair pathway of IR-
induced DNA damages and it is independent on cell cycle stages as discussed in 
Introduction. As shown in Fig. 6A, eIF3a knockdown significantly increased the NHEJ 
activity in H1299 cells by ~2 fold compared with the control H1299/Scr cells. Consistently, 
eIF3a over-expression significantly reduced the NHEJ activity in RIE cells by ~70% 
compared with the control RIE/Vec cells (Fig. 6B). These finding suggest that eIF3a 
expression may play an important role in suppressing NHEJ repair of DSBs.        
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FIGURE 6 
 
 
Figure 6. Role of eIF3a in NHEJ repair of IR-induced DSB. Host cell reactivity assay 
using reporter constructs were performed using H1299 cells with eIF3a knockdown (A) 
and RIE cells with stable eIF3a over-expression (B) as well as their respective control 
cells. 
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E. eIF3a regulates synthesis of NHEJ repair proteins. 
Because eIF3a is known to regulate synthesis of proteins, we hypothesized that 
eIF3a may regulate NHEJ repair of DSBs by regulating synthesis of NHEJ repair proteins. 
To test this hypothesis, we first performed a Western blot analysis of major proteins 
involved in NHEJ in H21299/Si, H1299/Scr, RIE/eIF3a, and RIE/Vec cells. As shown in 
Fig. 7A-B, eIF3a knockdown in H1299 cells drastically increased the expression of DNA-
PKcs, Ku70, and Ku80 proteins compared with the control H1299/Scr cells while eIF3a 
over-expression in RIE cells drastically reduced the expression of these proteins compared 
with the RIE/Vec control cells. Interestingly, real time RT-PCR analyses showed no 
change in the mRNA level of these genes, suggesting that the effect of eIF3a on the 
expression of DNA-PKcs, Ku70, and Ku80 is likely at the protein not mRNA level.   
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FIGURE 7 
 
 
Figure 7. Effect of eIF3a on expression genes encoding proteins important for NHEJ 
repair. Western blot and real-time RT-PCR analyses were performed to determine the 
effect of eIF3a on the expression of Ku70, Ku80, and DNA-PKcs genes in H1299 cells 
with transient knockdown (A) and RIE cells with stable eIF3a over-expression (B) as well 
as their respective control cells. 
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F. Effect of eIF3a on the synthesis rate and half-life of NHEJ proteins. 
To eliminate the possibility that eIF3a may influence the stability and the half-life 
of these NHEJ proteins, we next performed pulse labeling and protein stability assay to 
determine the eIF3a effect on synthesis and degradation rate of these DNA repair proteins, 
respectively. As shown in Fig. 8, eIF3a knockdown in H1299 cells using siRNA or eIF3a 
over-expression in RIE cells had no effects on the half degradation of these DNA repair 
proteins. However, the synthesis of Ku70, Ku80, and DNA-PKcs was dramaticacally 
increased by eIF3a knockdown in H1299 (Fig. 8A) and reduced by eIF3a over-expression 
in RIE cells (Fig. 8B).  Thus, eIF3a likely inhibits synthesis of Ku70, Ku80, and DNA-
PKcs proteins, leading to reduced repair of DSB by NHEJ pathway. 
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FIGURE 8 
 
Figure 8. Effect of eIF3a on the synthesis and degradation of Ku70, K80, and DNA-
PKcs. Pulse labeling and pulse-chase in combination with immunoprecipitation were 
performed to determine the synthesis (insets) and degradation, respectively, of Ku70, 
Ku80, and DNA-PKcs in H1299 cells with transient eIF3a knockdown (A) and RIE cells 
with stable eIF3a over-expression (B) as well as their respective control cells.  
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Conclusions and Discussion 
  
Appropriate combinations of radiation with chemotherapeutic drugs have resulted 
in remarkable outcome in cancer treatments. However, resistance to both radiation and 
anticancer drugs frequently occurs, causing failure in successful treatment or cure of human 
cancers. In this study, using cell line models we show that eIF3a may play important roles 
in cellular response to radiation by regulating NHEJ repair of DSB induced by radiation 
due to eIF3a suppression of synthesis of NHEJ proteins, Ku70, Ku80, and DNA-PKcs. 
These findings are consistent with previous observations that lower eIF3a expression 
associates with poor prognosis of several cancers [3-8].  
It is noteworthy that the difference in γ-H2AX protein level between cells with 
different eIF3a levels was observed very early (20 min) following IR treatments. Although 
eIF3a may protect cells from IR-induced DNA damage, it is more likely that the DSBs 
induced by IR can be much more quickly repaired in cells with low eIF3a level than cells 
with high eIF3a level considering that the basal level of DNA repair proteins are very 
different between these cells under eIF3a regulation.  
Together with previous findings [14, 15, 36], it is now clear that eIF3a likely plays 
an important role in regulating synthesis of DNA repair proteins. The fact that eIF3a does 
not contribute to cellular response to non-DNA-damaging drugs such as vinca alkaloid 
[14], suggests that eIF3a regulation of cellular response to DNA-damaging treatments is 
not an unspecific event in cellular response to anticancer drugs. Whether eIF3a also 
regulates the synthesis of proteins important for other DNA repair pathways such as 
homologous recombination for repair of DSBs remains to be determined. Nevertheless, the 
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findings that eIF3a may suppress the synthesis of DNA repair proteins and contribute to 
the increased sensitivity of cancer cells to DNA-damaging treatments suggest that eIF3a 
may be developed as a biomarker for precision medicine prescription. Patients with high 
level of eIF3a may benefit from DNA-damaging drugs and radiation whereas such 
treatments may not benefit as much for the patients with low level of eIF3a. 
In addition to the regulation in synthesis of DNA repair proteins, eIF3a has also been 
observed to possibly regulate the synthesis of p27, ribonucleotide reductase, and tubulin 
[9, 32]. In most of these cases, it was found that eIF3a suppresses the synthesis of these 
proteins. These findings are against the intuition and belief that eIF3a facilitates 
translational initiation as a subunit of eIF3 complex and its increased expression would 
increase protein synthesis. The fact that eIF3a suppresses the synthesis of some proteins 
while increase the synthesis of other proteins suggests that eIF3a may have an additional 
regulatory non-canonical function. How eIF3a regulates protein synthesis with its non-
canonical activity remains unknown. However, the previous finding that eIF3a can bind to 
the 5’-UTRs of RPA2 mRNA suggests that eIF3a may bind to these mRNAs and suppress 
the translation of these mRNAs. It also remains to be determined whether this non-
canonical activity requires other eIF3 subunits such as eIF3b. Recently, eIF3i has also been 
shown to be able to regulate the synthesis of COX2 suggesting that other eIF3 subunits 
may also have non-canonical activity although it is not clear if they work together. Clearly, 
more works are needed to investigate further the non-canonical function of eIF3 subunits 
in regulating protein synthesis. 
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